Clinical Trial Detail

NCT ID NCT04073615
Title Phase 1b/2 Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors LSK BioPartners Inc.
Indications

colorectal cancer

Therapies

Rivoceranib + trifluridine/tipiracil hydrochloride

Rivoceranib

trifluridine/tipiracil hydrochloride

Age Groups: senior adult

No variant requirements are available.